Alexandre Bazinet

1.2k total citations
38 papers, 365 citations indexed

About

Alexandre Bazinet is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Alexandre Bazinet has authored 38 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 18 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Alexandre Bazinet's work include Acute Myeloid Leukemia Research (31 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). Alexandre Bazinet is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). Alexandre Bazinet collaborates with scholars based in United States, Canada and Australia. Alexandre Bazinet's co-authors include Gizelle Popradi, Hagop M. Kantarjian, Sarit Assouline, Guillermo Montalban‐Bravo, Tapan M. Kadia, Guillermo Garcia‐Manero, Farhad Ravandi, Courtney D. DiNardo, Elias Jabbour and Gautam Borthakur and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Alexandre Bazinet

30 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Bazinet United States 9 221 155 87 56 51 38 365
Lixian Chang China 11 179 0.8× 134 0.9× 42 0.5× 89 1.6× 42 0.8× 58 348
Eun‐Hye Hur South Korea 10 226 1.0× 170 1.1× 75 0.9× 57 1.0× 69 1.4× 21 364
Gaku Oshikawa Japan 10 169 0.8× 152 1.0× 79 0.9× 23 0.4× 82 1.6× 29 326
Vicky Sandhu United States 8 270 1.2× 129 0.8× 79 0.9× 80 1.4× 57 1.1× 15 355
Chad P. Soupir United States 8 182 0.8× 64 0.4× 92 1.1× 46 0.8× 42 0.8× 9 304
Rocco Pastano Italy 10 177 0.8× 80 0.5× 74 0.9× 54 1.0× 66 1.3× 19 285
Sujaatha Narayanan Canada 10 181 0.8× 67 0.4× 81 0.9× 37 0.7× 61 1.2× 43 272
Yonggong Yang China 11 118 0.5× 90 0.6× 48 0.6× 58 1.0× 89 1.7× 33 325
A. Stamatoulas France 5 338 1.5× 286 1.8× 111 1.3× 76 1.4× 52 1.0× 9 449
Shaoyan Hu China 10 124 0.6× 176 1.1× 31 0.4× 59 1.1× 61 1.2× 77 325

Countries citing papers authored by Alexandre Bazinet

Since Specialization
Citations

This map shows the geographic impact of Alexandre Bazinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Bazinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Bazinet more than expected).

Fields of papers citing papers by Alexandre Bazinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Bazinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Bazinet. The network helps show where Alexandre Bazinet may publish in the future.

Co-authorship network of co-authors of Alexandre Bazinet

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Bazinet. A scholar is included among the top collaborators of Alexandre Bazinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Bazinet. Alexandre Bazinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bataller, Álex, Bofei Wang, Courtney D. DiNardo, et al.. (2025). Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions. Leukemia & lymphoma. 66(7). 1221–1233.
2.
Cho, Sung‐Yeon, Sebastian Wurster, Ying Jiang, et al.. (2025). Blastemia portrays a poor prognosis in acute leukemia patients with invasive pulmonary aspergillosis. Journal of Infection. 91(2). 106535–106535. 2 indexed citations
3.
Bataller, Álex, Alexandre Bazinet, Gautam Borthakur, et al.. (2024). Phase Ib/II Study of CPX-351 Plus Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML). Blood. 144(Supplement 1). 4272–4272.
4.
Bataller, Álex, Hagop M. Kantarjian, Alexandre Bazinet, et al.. (2024). Phase II Study of Cladribine with Low Dose Cytarabine and Venetoclax Alternating with Azacytidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia. Blood. 144(Supplement 1). 56–56. 3 indexed citations
5.
Chien, Kelly S., Juan José Rodríguez‐Sevilla, Guillermo Montalban‐Bravo, et al.. (2024). A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure.. Journal of Clinical Oncology. 42(16_suppl). 6570–6570. 1 indexed citations
6.
Bazinet, Alexandre, Ziyi Li, Juan José Rodríguez‐Sevilla, et al.. (2024). Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax. Clinical Cancer Research. 30(7). 1319–1326. 3 indexed citations
7.
8.
Chien, Kelly S., Juan José Rodríguez‐Sevilla, Yesid Alvarado, et al.. (2024). A Phase I Study of the Myeloid Cell Leukemia 1 (MCL1) Inhibitor Tapotoclax (AMG 176) in Patients With Myelodysplastic Syndromes After Hypomethylating Agent (HMA) Failure. Clinical Lymphoma Myeloma & Leukemia. 24. S195–S195.
9.
Csizmar, Clifford M., Mark E. Gurney, Rashmi Kanagal‐Shamanna, et al.. (2024). Prognostic Impact of the Number of TET2 Mutations in Myelodysplastic and Myeloproliferative Chronic Myelomonocytic Leukemia (CMML). Blood. 144(Supplement 1). 1820–1820. 1 indexed citations
10.
Bazinet, Alexandre, Hagop M. Kantarjian, Álex Bataller, et al.. (2024). Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial. The Lancet Haematology. 11(4). e287–e298. 13 indexed citations
11.
Bazinet, Alexandre, Courtney D. DiNardo, Álex Bataller, et al.. (2024). A retrospective comparison of abbreviated course “7+7” vs standard hypomethylating agent plus venetoclax doublets in older/unfit patients with newly diagnosed acute myeloid leukemia.. Journal of Clinical Oncology. 42(16_suppl). 6507–6507. 7 indexed citations
12.
Bataller, Álex, Alexandre Bazinet, Courtney D. DiNardo, et al.. (2023). Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood Advances. 8(4). 927–935. 36 indexed citations
13.
14.
Bazinet, Alexandre, Alan Wang, Xinmei Li, et al.. (2023). Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow. Cytometry Part B Clinical Cytometry. 106(4). 264–271. 7 indexed citations
15.
16.
Bataller, Álex, Alexandre Bazinet, Gautam Borthakur, et al.. (2023). Cladribine with Low Dose Cytarabine and Venetoclax Alternated with Azacytidine and Venetoclax for Acute Myeloid Leukemia: Prognostic Analysis of a Phase 2 Clinical Trial. Blood. 142(Supplement 1). 4256–4256. 9 indexed citations
17.
Bataller, Álex, Alexandre Bazinet, Sangeetha Venugopal, et al.. (2023). S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH VENETOCLAX IN TREATMENT-NAÏVE HIGHER-RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA. HemaSphere. 7(S3). e18588ff–e18588ff. 3 indexed citations
18.
Bazinet, Alexandre, Tapan M. Kadia, Sangeetha Venugopal, et al.. (2022). A retrospective study of cladribine and low‐dose cytarabine–based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia. Cancer. 129(4). 560–568. 6 indexed citations
19.
Bazinet, Alexandre & Gizelle Popradi. (2019). A General Practitioner’s Guide to Hematopoietic Stem-cell Transplantation. Current Oncology. 26(3). 187–191. 92 indexed citations
20.
Bazinet, Alexandre, Celia M.T. Greenwood, Christian D. Young, et al.. (2019). A 10-Color Flow Cytometry Panel for Both Diagnosis and Minimal Residual Disease Measurement in Chronic Lymphocytic Leukemia. Blood. 134(Supplement_1). 5451–5451. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixian Chang Breakdown of academic impact, for papers by Eun‐Hye Hur Breakdown of academic impact, for papers by Gaku Oshikawa Breakdown of academic impact, for papers by Vicky Sandhu Breakdown of academic impact, for papers by Chad P. Soupir Breakdown of academic impact, for papers by Rocco Pastano Breakdown of academic impact, for papers by Sujaatha Narayanan Breakdown of academic impact, for papers by Yonggong Yang Breakdown of academic impact, for papers by A. Stamatoulas Breakdown of academic impact, for papers by Shaoyan Hu
Rankless by CCL
2026